ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Anti-TALLA-1 Antibody [B2D] (APC) (A121895)

Mouse monoclonal [B2D] antibody to TALLA-1 (APC) for Flow Cytometry.

Alternative Formats and ConjugatesAlternative Formats

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 5-8 business days.
Name
Anti-TALLA-1 Antibody [B2D] (APC)
Description
Mouse monoclonal [B2D] antibody to TALLA-1 (APC).
Specificity
This antibody recognizes an extracellular epitope of CD231, a transmembrane glycoprotein expressed in neuronal tissue and T-ALL.
Applications
Flow Cytometry
Dilutions
Flow Cytometry: The reagent is designed for analysis of human blood cells using 10 µl reagent / 100 µl of whole blood or 106 cells in a suspension. The content of a vial (1 ml) is sufficient for 100 tests.
Reactivity
Human
Immunogen
Human T-ALL cell line THP-6.
Host
Mouse
Clonality
Monoclonal
Clone ID
B2D
Isotype
IgG1
Conjugate

APC

Excitation: 645nm, Emission: 660nm

Purification
This antibody is conjugated with Allophycocyanin (APC) under optimum conditions. The conjugate is purified by size-exclusion chromatography; removing unconjugated antibody and free fluorochrome.
Product Form
Liquid
Formulation
Supplied in Phosphate Buffered Saline, pH 7.4, with 15 mM Sodium Azide.
Storage
Shipped at 4°C. Store in the dark at 2-8°C. Do not freeze!
Synonyms
A15, CD231, Cell surface glycoprotein A15, DXS1692E, Membrane component chromosome X surface marker 1, MXS1, T-cell acute lymphoblastic leukemia-associated antigen 1, Tetraspanin-7, TM4SF2, Transmembrane 4 superfamily member 2, Tspan-7
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Anti-TALLA-1 Antibody [B2D] (APC) (A121895)? Please let us know so that we can list the citation on this page.

Proteins predicted to interact with TSPAN7

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
97.3% Relevancy Score
66.2% Relevancy Score
59.2% Relevancy Score
56.2% Relevancy Score
55.6% Relevancy Score
54.8% Relevancy Score
52.6% Relevancy Score
52.2% Relevancy Score
48.5% Relevancy Score